These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12402789)

  • 41. [Leucine aminopeptidase activity in the cerebrospinal fluid in nervous system diseases].
    Buchinger W; Hohenegger M
    Wien Klin Wochenschr; 1969 Dec; 81(50):920-1. PubMed ID: 5380795
    [No Abstract]   [Full Text] [Related]  

  • 42. Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.
    Menculini G; Chipi E; Paolini Paoletti F; Gaetani L; Nigro P; Simoni S; Mancini A; Tambasco N; Di Filippo M; Tortorella A; Parnetti L
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Free radicals and antioxidants].
    Vladimirov IuA
    Vestn Ross Akad Med Nauk; 1998; (7):43-51. PubMed ID: 9720415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Detection of interferon-gamma and IL-6 producing cells in cerebrospinal fluid cells in the central nervous system infectious diseases using immunocytochemistry].
    Nakamura S; Nagano I; Yoshioka M; Onodera J; Kogure K
    Rinsho Shinkeigaku; 1992 Feb; 32(2):143-7. PubMed ID: 1611772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [On the demonstration of plasma cells in the cerebrospinal fluid in neurological diseases].
    Greger J; Wieczorek V
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(4):366-74. PubMed ID: 4226908
    [No Abstract]   [Full Text] [Related]  

  • 46. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
    Bernheimer H; Birkmayer W; Hornykiewicz O
    Wien Klin Wochenschr; 1966 Jun; 78(23):417-9. PubMed ID: 4229554
    [No Abstract]   [Full Text] [Related]  

  • 48. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
    Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S
    Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Free radicals and antioxidants in the development and functions of the central nervous system: from fetus to aging. April 18-20, 2001. Saint Petersburg, Russia. Abstracts.
    Adv Gerontol; 2001; 6():6-77. PubMed ID: 11762302
    [No Abstract]   [Full Text] [Related]  

  • 50. Low cerebrospinal fluid prolactin levels in patients with central cerebral atrophy.
    Hyyppä MT; Tenkku M; Liira J; Jäykkä H
    J Neurol Sci; 1980 Jul; 47(1):145-6. PubMed ID: 7411161
    [No Abstract]   [Full Text] [Related]  

  • 51. Free radicals: trick or treat?
    McNamee D
    Lancet; 1994 Sep; 344(8924):702. PubMed ID: 7915772
    [No Abstract]   [Full Text] [Related]  

  • 52. [Progressive and extensive hereditary, familial degeneration of the cerebrospinal system].
    RAYBAUD A; BADETTI L
    Sem Hop; 1953 May; 29(35):1764-6. PubMed ID: 13076449
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases.
    Chapple IL
    Clin Mol Pathol; 1996 Oct; 49(5):M247-55. PubMed ID: 16696085
    [No Abstract]   [Full Text] [Related]  

  • 54. Selections from current literature: the role of free radicals and antioxidants in disease.
    Trilling JS; Jaber R
    Fam Pract; 1996 Jun; 13(3):322-6. PubMed ID: 8671143
    [No Abstract]   [Full Text] [Related]  

  • 55. On a Variety of Uterine Hemorrhagy Not Hitherto Described.
    Heming GO
    Edinb Med Surg J; 1831 Oct; 36(109):385-389. PubMed ID: 30329917
    [No Abstract]   [Full Text] [Related]  

  • 56. Association between aromatic amines and serum neurofilament light chain as a biomarker of neural damage: a cross-sectional study from NHANES.
    Lin T; Mao H; Huang S; Chen J
    Front Public Health; 2024; 12():1344087. PubMed ID: 39381758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxidants and antioxidants in hypoxic ischaemic encephalopathy.
    Thorat VN; Suryakar AN; Sardeshmukh AS; Sarawade SS
    Indian J Clin Biochem; 2004 Jul; 19(2):32-5. PubMed ID: 23105453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Free radicals and antioxidants in cerebrospinal fluid in central nervous system diseases].
    Holecek V; Racek J; Trefil L; Rokyta R
    Cesk Fysiol; 2002 Aug; 51(3):129-32. PubMed ID: 12402789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrospinal fluid Diacron-Reactive Oxygen Metabolite levels in pediatric patients with central nervous system diseases.
    Yamanaka G; Ishii C; Kawashima H; Oana S; Miyajima T; Hoshika A
    Pediatr Neurol; 2008 Aug; 39(2):80-4. PubMed ID: 18639749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Free radical damage and oxidative stress in Huntington's disease.
    Borlongan CV; Kanning K; Poulos SG; Freeman TB; Cahill DW; Sanberg PR
    J Fla Med Assoc; 1996 May; 83(5):335-41. PubMed ID: 8666972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.